Evidence map›Paper›PMID 8794012›Full record

ReviewCurrent opinion in immunology1996

Primary and secondary immune responses to Listeria monocytogenes.

J T Harty, L L Lenz, M J Bevan

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in immunology, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 87 citations in OpenAlex.

  1. STING controls T cell memory fitness during infection through T cell-intrinsic and IDO-dependent mechanisms.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  2. Article
  3. RecombinantFrontiers in microbiology · 2022
    Article
  4. Article
  5. Acute Exposure to the Food-Borne PathogenJournal of inflammation research · 2021
    Article
  6. Article
  7. Pathogens (Basel, Switzerland) · 2018
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Listeria-based cancer vaccines that segregate immunogenicity from toxicity.Proceedings of the National Academy of Sciences of the United States of America · 2004
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

J T HartyDepartment of Microbiology, The University of Iowa, Iowa City, IA 52242, USA. john-harty@uiowa.edu
L L Lenz
M J Bevan
Howard Hughes Medical Institute · USUniversity of Iowa · USUniversity of Washington · US

Funding

CYTOTOXIC RESPONSE TO HISTOCOMPATIBILITY ANTIGENSR01AI019335 · NIAID · UNIVERSITY OF WASHINGTON · PI BEVAN, MICHAEL J · 1985 to 2012
$4.4M
SPECIFICITY OF CD8 T CELLS AGAINST L MONOCYTOGENESR29AI036864 · NIAID · UNIVERSITY OF IOWA · PI HARTY, JOHN T. · 1995 to 1999
–
Howard Hughes Medical InstituteNIAID NIH HHS AI 36864NIAID NIH HHS R01 AI019335NIAID NIH HHS R29 AI036864
6 · The paper itself

Abstract

Recent studies have revealed the complexity of cytokine and cellular interactions required for resistance to primary Listeria monocytogenes infection and have illustrated that resistance to secondary infection may occur through multiple pathways. Analyses of Listeria epitope generation and the specificity of protective CD8(+) T cells have suggested that future research should focus on secreted protein antigens in specific resistance to infection and have increased our understanding of Listeria antigens presented by MHC class l-b molecules.

Indexed as

AnimalsCD8-Positive T-LymphocytesImmunologic MemoryListeria monocytogenes

Identifiers

PMID8794012
PMCPMC2784914
OpenAlexW2064652792

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.